POLALA.COM
welcome to my space
X
Web Design | Video Games | RVs | Religion | Management | Supplements and Vitamins | Software | Basketball | Related articles
Welcome to:polala.com
Search:  
NAVIGATION: Home >>
My Rare Disease - Best Approach
Published by: webmaster 2009-01-07
  • I have Acute Intermittent Porphryia. Recently all the "right" urine tests came up negative. I'm too muddled to sort out the reasonable possiblities for error (they may have been run too late in an attack) vs the real possiblities that I may have another variation altogether, or a "hybrid" which seems to occur in women my age (62) more often doctors would like to think. There are so few of us, nobody really knows anything, except that glucose certainly turns off an attack. I need to create my own investigative/testing algorithm. If I've set price too low and better research is possible, please let me know! This is just for openers.


  • Hello Sara44, Acute intermittent porphyria is a subtype of porphria, a rare and very interesting genetic disease. AIP occurs in 1.5 persons out of 100,000 people, with an increased incidence in England, Ireland, and Sweden. ?Acute intermittent porphyria is inherited in an autosomal dominant pattern, which means one copy of the altered gene is sufficient to decrease enzyme activity and cause symptoms.? http://ghr.nlm.nih.gov/condition=acuteintermittentporphyria ?Acute intermittent porphyria - Acute intermittent porphyria (AIP) is also known as Swedish porphyria, pyrroloporphyria, and intermittent acute porphyria. AIP is inherited as an autosomal dominant trait, which means only one copy of the defective gene needs to be present for the disorder to occur. However, simply inheriting this gene does not necessarily mean that a person will develop the disease. Approximately 5-10 per 100,000 persons in the United States carry the gene, but only10% of them ever develop AIP symptoms.? ?Treatment for acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria follows the same basic regime. A person who has been diagnosed with one of these porphyrias can prevent most attacks by avoiding precipitating factors, such as certain drugs that have been identified as triggers for acute porphyria attacks. Individuals must maintain adequate nutrition, particularly in respect to carbohydrates. In some cases, an attack can be stopped by increasing carbohydrate consumption or by receiving carbohydrates intravenously. If an attack occurs, medical attention is needed. Pain is usually severe, and narcotic analgesics are the best option for relief. Phenothiazines can be used to counter nausea, vomiting, and anxiety, and chloral hydrate or diazepam is useful for sedation or to induce sleep. An intravenously administered drug called hematin may be used to curtail an attack. It seems to work by signaling the heme biosynthesis pathway to slow production of precursors.? http://porphyria.blogspot.com/2003_03_30_porphyria_archive.html ?The porphyrias are inherited conditions, and the genes for all enzymes in the heme pathway have been identified. Some forms of porphyria result from inheriting an abnormal gene from one parent (autosomal dominant). Other forms are from inheriting an abnormal gene from each parent (autosomal recessive). The risk that individuals in an affected family will have the disease or transmit it to their children is quite different depending on the type.? http://digestive.niddk.nih.gov/ddiseases/pubs/porphyria/ ?The predominant problem appears to be neurologic damage that leads to peripheral and autonomic neuropathies and psychiatric manifestations. Although patients with acute attacks always have elevations of porphobilinogen and ALA, how this leads to the symptomatic disease is still unclear because most patients with the genetic defect have excessive porphyrin secretion but no symptoms.? ?The classic inducers of porphyria are chemicals or situations that boost heme synthesis. This includes fasting and many medications. Although very large lists of "safe" and "unsafe" drugs exist, many of these are based on anecdotes or laboratory evidence and do not meet strict criteria. In general, drugs that lead to increased activity of the hepatic P450 system, such as phenobarbital, sulfonamides, estrogens, and alcohol, are associated with porphyria.? ?Fasting for several days also can trigger an attack. However, many attacks occur without any obvious provocation.? http://www.emedicine.com/med/topic1880.htm ?Most people with a deficiency of porphobilinogen deaminase never develop symptoms. In some people, however, certain factors?drugs, hormones, or diet?can precipitate symptoms, producing an attack. Many drugs (including barbiturates, anticonvulsants, and sulfonamide antibiotics) can bring on an attack. Hormones, such as progesterone and related steroids, can precipitate symptoms, as can low-calorie and low-carbohydrate diets, large amounts of alcohol, or smoking. Stress resulting from an infection, another illness, surgery, or a psychologic upset is also sometimes implicated. Usually a combination of factors is involved. Sometimes the factors that cause an attack cannot be identified.? http://www.merck.com/mmhe/sec12/ch160/ch160c.html =============== Diagnosing AIP =============== ?There are seven main types of porphyria (fig 1), which are broadly classified according to clinical features into neuropsychiatric, dermatological, and mixed forms. Acute intermittent porphyria and plumboporphyria are predominantly neuropsychiatric; congenital erythropoietic porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria have predominantly cutaneous manifestations; and hereditary coproporphyria and variegate porphyria are classified as mixed as they may have both cutaneous and neuropsychiatric features. The prevalence of porphyria varies widely from country to country and also depends on the type of porphyria. Overall prevalence of overt cases in the United Kingdom is about 1 in 25 000 population for porphyria cutanea tarda and less than 1 in one million for congenital erythropoietic porphyria.1 Plumboporphyria has not been reported in Britain.? ??not all symptoms in porphyric patients are due to porphyria porphyric patients are not immune to other conditions.? ?Routine laboratory screening tests may be unreliable,14 but a recently introduced screening kit seems promising.15 A clue to the diagnosis is that the urine is often dark on standing owing to polymerisation of porphobilinogen to porphyrins and other pigments. Between attacks, however, concentrations of urinary porphobilinogen and particularly aminolaevulinic acid are often normal. Plasma fluorescence is usually increased in variegate porphyria and is valuable both diagnostically and for family studies.? http://bmj.bmjjournals.com/cgi/content/full/320/7250/1647 ?The isolation and characterization of the gene for PBG deaminase has brought molecular techniques for diagnosing the disease within reach. Over 60 mutations causing acute intermittent porphyria have been found, most of which are confined to one or several families. Because no single mutation accounts for more than a fraction of cases, screening techniques for locating and identifying unknown mutations are very important. Once a mutation has been characterized, testing of family members is straightforward, and gene carriers can be identified or excluded with greater accuracy than is possible with conventional biochemical tests.? http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8838232&dopt=Abstract ?The best time to be tested for porphyria is at the earliest opportunity. In practice, this means that families should be offered screening for acute porphyria as soon as possible after a relative has been found to have the condition. When one or other parent is already known to have an acute porphyria, their children should be tested as soon as practicable. It is worth enquiring about this during pregnancy as your doctor will then be able to find out when your baby should be tested. In some cases, it is now possible to test baby at birth but it may be necessary to wait until your child is one year old or, occasionally, even older. There are two main advantages of early diagnosis. First, those who are found to have inherited one of the acute porphyrias can be advised about how to reduce the risk of an acute attack. Second, if an acute attack does develop, your doctor will be able to make the diagnosis and start special treatment early. The symptoms of an attack of acute porphyria are not always easy to recognise and, if the condition is not already diagnosed, there is a risk that your doctor will use drugs that may make the attack worse or may even think that an operation is necessary.? ?For relatives who have not had an acute attack, and especially for children, urine testing is usually unhelpful. For these people, special tests on blood, and sometimes urine or faeces as well, need to be carried out in a specialist reference laboratory (more about porphyria specialist centres). For some families, it is now becoming possible to use DNA tests to detect the gene mutation that causes porphyria. DNA tests are more accurate than other methods but are complicated and are not yet available for all families. Your doctor should be able to arrange specialist testing for you. If you live a long way from a specialist porphyria laboratory, the samples can easily be sent by post following specific advice.? http://www.porphyria-europe.com/01-for-patients/EN/for-patients.asp#07 ?One should never accept a diagnosis of porphyria based on clinical symptoms alone. Skin symptoms suggestive of photosensitivity are indeed sufficient reason to have a patient tested for porphyria, as are are symptoms suggestive of the acute attack. Bear in mind however that appropriate diagnostic laboratory tests must be regarded as more sensitive and specific than the clinical history alone. In particular, to have any relevance, the skin symptoms and possible acute symptoms must be consistent with these diagnoses.? ?A point often not appreciated by both patients and doctors is that an accurate set of diagnostic results will provide more information than merely confirming that porphyria is present. In order to manage the patient appropriately, we require the following information from our diagnostic testing: ? a definitive diagnosis of the type of porphyria. ? an estimation of the biochemical activity of the porphyria. (In general there is a relationship between the the degree of elevation of urine ALA, PBG and porphyrins and the likelihood that acute symptoms are due to porphyria.) ? identification of the mutation responsible for the porphyria in the patient (which is of great value in subsequent screening of the family). http://web.uct.ac.za/depts/porphyria/professional/prof%20diagnosis%20intro.htm Here is a chart of the most common symptoms http://bmj.bmjjournals.com/cgi/content/full/320/7250/1647/F2 ======= Testing ======= ??the diagnosis of AIP and other types of porphyria is sometimes made incorrectly in patients who do not have porphyria at all, particularly if laboratory tests are improperly done or misinterpreted. The finding of increased levels of delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine establishes that one of the acute porphyrias is present. If PBGD is deficient in normal red blood cells then the diagnosis of AIP is established. However, measuring PBGD in red blood cells should not be relied upon by itself to exclude AIP in a sick patient, because the enzyme is not deficient in red blood cells of all AIP patients.? ?However, in some AIP families, PBGD is normal in red blood cells and is deficient only in the liver and other tissues. Falsely low values sometimes occur due to problems with collecting and transporting the sample.? As a health care professional myself, I can tell you that handling of specimens is a huge problem. Specimens MUST be processed correctly and kept from light at all times. A delay in transport, specimen collection and labeling, and delay in testing can alter results. If possible, try to collect your samples (except 24 hour samples, of course) at the performing lab to avoid transport delays. Make sure the samples are well protected from light. Wrap containers with an old rag, then cover with foil, so no light enters the container. Ask the technician or nurse collecting your samples to cover the tubes immediately after drawing them. http://www.porphyriafoundation.com/about_por/types/types01.html ?Porphyrin tests are assays that are used to help diagnose, and monitor a group of disorders called porphyrias. Most porphyrin tests detect and measure the by-products of heme synthesis. Heme is a part of hemoglobin (the protein inside red blood cells that allows them to transport oxygen) and a number of other proteins. The synthesis of heme is a step-by-step process that requires the sequential action of eight different enzymes. If there is a deficiency in one of these enzymes, a bottleneck forms and precursors build up in the body?s fluids and tissues and are excreted in urine and feces. Which precursors build up depends on where the bottleneck is.? Individual Tests Clinical laboratories measure porphyrins and their precursors in urine, blood, and feces. These tests are listed below: ? Delta-aminolevulinic acid (ALA) in urine ? Porphobilinogen (PBG) in urine ? Porphyrins in urine, feces, or blood ? Zinc protoporphyrin (or free erythrocyte protoporphyrin) in red blood cells http://www.labtestsonline.org/understanding/analytes/porphyrines/sample.html ?It is less widely appreciated that incorrect diagnoses of porphyria are common in patients with symptoms due to other diseases. Therefore, in patients with a past history of porphyria, it is important to review the laboratory data that were the basis for the original diagnosis. Further testing may be necessary if the diagnosis was not adequately documented. Incorrect diagnoses of porphyria can occur in patients having minimal abnormalities in laboratory tests, such as small elevations in urinary porphyrins or porphyrin precursors that in fact have little or no diagnostic significance. Incorrect diagnoses are less likely if reliance is placed on a few first-line tests in most clinical situations, as described above.? http://www.porphyriafoundation.com/about_por/testing/testing01g.html This testing flow chart will be useful to you: http://www.porphyriafoundation.com/about_por/testing/testing01aa.html ?Laboratory tests performed on samples of urine show increased levels of two heme precursors (delta-aminolevulinic acid and porphobilinogen). Levels of these precursors are very high during attacks and remain high in people who have repeated attacks. The precursors can form porphyrins, which are reddish in color, and other substances that are brownish. These turn the urine dark, especially after exposure to light.? ?Attacks of acute intermittent porphyria can be prevented by maintaining good nutrition and avoiding the drugs that can provoke them. Crash diets to lose weight rapidly should be avoided. Heme can be given to prevent attacks. Premenstrual attacks in women can be prevented with one of the gonadotropin-releasing hormone agonists used to treat endometriosis (see Endometriosis), although this treatment is still investigational.? http://www.merck.com/mmhe/sec12/ch160/ch160c.html ??The fundamental step in diagnosing acute intermittent porphyria (AIP) is to demonstrate increased urinary porphobilinogen secretion. If a patient has no increased secretion of porphobilinogen, acute porphyria is eliminated as a cause of the neurovisceral symptoms. o A common error is the failure to order urine porphyrins. Porphobilinogen, a porphyrin precursor, usually is not included in a urine porphyrin screen and must be ordered specially. o AIP patients have elevated porphobilinogen between attacks. oI n some patients with a remote (years) history of attacks, porphobilinogen can return to the reference range. ?Other nonspecific signs in an attack of AIP include hyponatremia, (Low blood sodium) syndrome of inappropriate secretion of antidiuretic hormone (SIADH), and mild leukocytosis (increased white blood cell count). ?Although a defective enzyme causes AIP, measuring the activity of porphobilinogen deaminase is of little value. o Approximately 10% of AIP patients will have normal activity because a different form of the enzyme is expressed in the hematopoietic tissues. o The vast majority of patients with the defective enzyme do not have any symptoms of the disease. ?The treatment goal for acute attacks of porphyria is to decrease heme synthesis and reduce the production of porphyrin precursors. o High doses of glucose (400 g/d) can inhibit heme synthesis and are useful for treatment of mild attacks. o People experiencing severe attacks, especially those with severe neurologic symptoms, should be treated with hematin in a dose of 4 mg/kg/d for 4 days. ?Pain control is best achieved with narcotics. Laxatives and stool softeners should be administered with the narcotics to avert exacerbating existing constipation. ?Treat seizures with Neurontin. Most classic antiseizure medicines can lead to acute porphyria attacks. ?The patient should receive a high-carbohydrate diet during the attack. If the patient is unable to eat, intravenous glucose should be administered. ?Between attacks, eating a balanced diet is more important than eating one rich in glucose. http://www.emedicine.com/med/topic1880.htm ?Acute Attack Porphyria: Test for urine porphobilinogen. Urine PBG is the single most important test if an acute porphyria is suspected. During an acute attack, urine PBG is markedly elevated. A random urine sample collected during a symptomatic episode is an excellent specimen for the evaluation of an acute porphyria. Alternatively, a 24-hour urine specimen may be collected. Aminolevulinic acid (ALA) is also typically elevated during an acute attack.? ?It is difficult to diagnosis latent acute porphyria because concentrations of PBG typically normalize between attacks and more than 90 percent of individuals who carry the gene defect never suffer from an acute attack. Enzyme concentrations can, in theory, identify individuals at risk. For example, in individuals predisposed to acute intermittent porphyria, the concentration of the enzyme PBG deaminase is typically half that seen in unaffected individuals. (See also: Porphobilinogen (PBG) Deaminase, Erythrocyte.) Technical difficulties limit the usefulness of enzyme assays, however, and gene-based assays may prove to be more reliable.? Please see this cached site for the normal ranges of urine porphobilinogen. http://66.102.7.104/search?q=cache:XWhgRLqJdekJ:www.aruplab.com/guides/clt/tests/clt_162b.jsp+Acute+Intermittent+Porphyria+%2B+testing+algorithm&hl=en&gl=us&ct=clnk&cd=2 Urine porphyrin and precursor analysis ?This may confirm a diagnosis of acute intermittent porphyria or porphyria cutanea tarda, and is the most appropriate way to assess the biochemical activity of variegate porphyria.? DNA analysis ?A common problem is the patient who has had an incomplete sets of tests performed. Typically this comprises a DNA test for the common South African mutation without appropriate biochemical urine and plasma porphyrin analysis. Such a test will not detect forms of porphyria other than R59W-positive VP, and provides no information on biochemical activity.? http://web.uct.ac.za/depts/porphyria/professional/prof%20diagnosis%20intro.htm ?What investigation should be done if Porphyria is suspected? ? biochemistry - hyponatraemia, hypomagnesaemia and hypovolaemia may occur during acute attacks ? definitive test is porphobilinogen deaminase in erythrocytes which is decreased by 50% ? urine - usually normal colouration when fresh but becomes brown, red or black on standing; marked increase in porphobilinogen (PBG); slightly elevated coproporphyrin and uroporphyrin ? stool - coproporphyrin and protoporphyrin normal ? liver function tests - sulfobromophthalein retention ? increased serum cholesterol, serum iron and T4 ? hyperbetalipoproteinemia ? abnormal glucose tolerance What is the Ehrlich Aldehyde Test ? Ehrlich's aldehyde test is used to confirm a diagnosis of acute intermittent porphyria. Ehlich's aldehyde reagent consists of p-dimethyl amino benzaldehyde in acid solution. Equal volumes of urine and Ehrlich's reagent are mixed. If a pink colour is formed this indicates a raised urinary concentration of either porphobilinogen or urobilinogen. In cases of raised porphobilinogen, as in acute intermittent porphyria, the pink precipitate is observed to be insoluble in chloroform.? This site is now closed, so if you find the information useful, you may wish to copy the pages. It is unknown how long this page will be online. http://members.tripod.com/~theaipforum/ ====================== Additional Information ====================== ?A genetic counselor can review your family history and risks for this disorder in you and your offspring and discuss appropriate testing that is available for you. Although the genetic mutation cannot be corrected, attacks can be anticipated, prevented, or controlled. Steps to avoid porphyria attacks and complications include the following: ?Avoid drugs and other triggers ?Protect skin from injury or infection http://www.brighamandwomens.org/search.aspx?st=1&qt=AIP&submitButton.x=0&submitButton.y=0&submitButton=submit From the University of Cape Town, I found this great glossary of porphyria terms form you! http://web.uct.ac.za/depts/porphyria/patient/pat%20glossary.htm Porphyria Education materials from the Porpria Foundation http://www.porphyriafoundation.com/education.html For further AIP education, consider these books: http://www.uq.edu.au/porphyria/reading.html I hope you found this information useful. If anything is unclear, please request an Answer Clarification, and allow me to respond, before your rate this answer! I wish you the best! Sincerely, Crabcakes Search Terms ============ Ehrlich's aldehyde test + porphyria Porphobilinogen + urobilinogen Watson-Swartz Acute Intermittent Porphyria + testing algorithm AIP + glucose AIP + testing flow chart Coping with AIP
  • Rare Disease - Kosmix::
    My Rare Disease - Best Approach - 3 replies. genetic disease. AIP occurs in 1.5 persons out of 100000 people, with an increased this gene does not
    http://www.kosmix.com/topic/Rare_disease
    HOME
    President’s Podium::
    File Format: PDF/Adobe Acrobat - View as HTMLI felt the best approach would be to assemble experts and those directly involved so diseases explained that it is extremely rare for one to become ill
    http://www.kcifma.com/newsletter/December2003.pdf
    HOME
    Diagnostic Guides Online for Joint symptoms - WrongDiagnosis.com::
    The best approach to analysis of this symptom is anatomic and histologic ( Table 43 ). However, if one remembers the biochemical causes of joint disease,
    http://www.wrongdiagnosis.com/symptoms/joint_symptoms/sections.htm
    HOME



    Where's The Advantage In Windows Genuine Advantage?
    Stocks Bounce After S&P Joins Bear Market
    PRINT Add to favorites
    #If you have any other info about this subject , Please add it free.#
    Your name:
    E-mail:
    Telphone:

    Your comments:


    If you have any other info about My Rare Disease - Best Approach , Please add it free.
  • find the phraze with condition
  • word 2003 problem with calculated field form
  • summary table in word
  • print a date
  • mailmerge with images
  • inserting a spreadsheet into a word doc
  • printing word documents with embedded excel files
  • svaing document more than 1 time by vba
  • mail merge automation
  • copying text from form fields into other form fields
  • ms word 2003 file menu glitch please help
  • get from word to excel
  • excel formula word problem
  •  
  • highlight items in word 2002
  • word 2003 close inexpectly
  • word footers
  • select 1 and only 1 form field
  • mail merge fields format incorrectly
  • keeping number format when mail merging
  • how to identify the macro assigned to a toolbar button
  • having trouble with word 2003 table calculations
  • reviewing word 2003
  • vba newbie i know the desired end result but not how to get there
  • my word prints a hyperlink instead of the picture
  • macro hotkeys
  • word 2000 page numbers
  • regular font in times new roman
  • About us |Contact us |Advertisement |Site map |Exchange links
    Copyright© 2008polala.com All Rights Reserved